Display options
Share it on

Brain Sci. 2020 Feb 13;10(2). doi: 10.3390/brainsci10020102.

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations.

Brain sciences

Grace Blest-Hopley, Vincent Giampietro, Sagnik Bhattacharyya

Affiliations

  1. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AB, UK.
  2. Department of Neuroimaging, Centre for Neuroimaging Sciences, PO Box 089, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AB, UK.
  3. South London and Maudsley NHS Foundation Trust, Denmark Hill, Camberwell, London SE5 8AB, UK.

PMID: 32069958 PMCID: PMC7071506 DOI: 10.3390/brainsci10020102

Abstract

Cannabis has been associated with deficits in memory performance. However, the neural correlates that may underpin impairments remain unclear. We carried out a systematic review of functional magnetic resonance imaging (fMRI) studies investigating brain functional alterations in cannabis users (CU) compared to nonusing controls while performing memory tasks, complemented with focused narrative reviews of relevant preclinical and human studies. Twelve studies employing fMRI were identified finding functional brain activation during memory tasks altered in CU. Memory performance studies showed CU performed worse particularly during verbal memory tasks. Longitudinal studies suggest that cannabis use may have a causal role in memory deficits. Preclinical studies have not provided conclusive evidence of memory deficits following cannabinoid exposure, although they have shown evidence of cannabinoid-induced structural and histological alteration. Memory performance deficits may be related to cannabis use, with lower performance possibly underpinned by altered functional activation. Memory impairments may be associated with the level of cannabis exposure and use of cannabis during developmentally sensitive periods, with possible improvement following cessation of cannabis use.

Keywords: THC; cannabis; functional magnetic resonance imaging; memory; systematic review

References

  1. Neurology. 2006 Mar 14;66(5):737-9 - PubMed
  2. Psychopharmacology (Berl). 1982;77(2):117-23 - PubMed
  3. Biol Psychiatry. 2012 Apr 15;71(8):693-9 - PubMed
  4. Arch Gen Psychiatry. 2012 Jan;69(1):27-36 - PubMed
  5. Curr Pharm Des. 2014;20(13):2168-85 - PubMed
  6. Psychopharmacology (Berl). 2011 Jul;216(1):131-44 - PubMed
  7. J Clin Exp Neuropsychol. 2017 Jun;39(5):502-512 - PubMed
  8. Neurotoxicol Teratol. 1995 Jan-Feb;17(1):25-30 - PubMed
  9. Psychopharmacology (Berl). 2000 Jul;151(1):19-24 - PubMed
  10. Eur J Neurosci. 2004 Aug;20(3):859-63 - PubMed
  11. Addict Behav. 2013 Sep;38(9):2450-4 - PubMed
  12. Science. 2003 Jan 24;299(5606):577-80 - PubMed
  13. Neurotoxicol Teratol. 2010 Sep-Oct;32(5):515-24 - PubMed
  14. J Neurosci. 2005 Jun 15;25(24):5720-9 - PubMed
  15. Am J Addict. 2015 Jan;24(1):47-52 - PubMed
  16. J Psychopharmacol. 2004 Dec;18(4):502-8 - PubMed
  17. Behav Pharmacol. 2007 Sep;18(5-6):563-9 - PubMed
  18. Cannabis Cannabinoid Res. 2018 Mar 01;3(1):56-65 - PubMed
  19. Curr Drug Abuse Rev. 2008 Jan;1(1):81-98 - PubMed
  20. Psychol Med. 2004 Oct;34(7):1239-50 - PubMed
  21. J Am Acad Child Adolesc Psychiatry. 2010 Jun;49(6):561-72, 572.e1-3 - PubMed
  22. Drug Alcohol Depend. 2018 Jul 1;188:71-78 - PubMed
  23. Neurotoxicol Teratol. 2005 Mar-Apr;27(2):231-9 - PubMed
  24. Biol Psychiatry. 2016 Apr 1;79(7):557-67 - PubMed
  25. JAMA Intern Med. 2016 Mar;176(3):352-61 - PubMed
  26. Neuropsychol Rev. 2016 Jun;26(2):186-222 - PubMed
  27. Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E500-8 - PubMed
  28. J Psychopharmacol. 2006 May;20(3):373-84 - PubMed
  29. Brain. 2003 May;126(Pt 5):1202-23 - PubMed
  30. Neuroimage. 2008 Apr 15;40(3):1328-39 - PubMed
  31. Hippocampus. 2010 Nov;20(11):1178-94 - PubMed
  32. Cogn Affect Behav Neurosci. 2004 Dec;4(4):528-39 - PubMed
  33. Front Behav Neurosci. 2013 Nov 19;7:162 - PubMed
  34. Neuropsychopharmacology. 2015 May;40(6):1343-52 - PubMed
  35. Hippocampus. 2009 Aug;19(8):763-72 - PubMed
  36. Brain Sci. 2018 Feb 27;8(3): - PubMed
  37. Psychopharmacology (Berl). 2006 Apr;185(3):358-68 - PubMed
  38. Psychopharmacology (Berl). 2006 Nov;188(4):425-44 - PubMed
  39. Neurotoxicol Teratol. 2007 Jan-Feb;29(1):1-9 - PubMed
  40. Psychiatry Res. 2008 May 30;163(1):40-51 - PubMed
  41. Am J Drug Alcohol Abuse. 2018;44(1):4-18 - PubMed
  42. Pharmacol Biochem Behav. 2009 Oct;93(4):482-90 - PubMed
  43. Neuropsychopharmacology. 2008 Oct;33(11):2760-71 - PubMed
  44. Psychopharmacology (Berl). 2019 Dec 9;: - PubMed
  45. Neurosci Biobehav Rev. 2018 May;88:26-41 - PubMed
  46. Neuropsychopharmacology. 2014 Aug;39(9):2041-8 - PubMed
  47. Neuropsychologia. 1997 May;35(5):657-67 - PubMed
  48. Exp Clin Psychopharmacol. 2012 Oct;20(5):420-429 - PubMed
  49. Microsc Res Tech. 2000 Oct 1;51(1):6-28 - PubMed
  50. Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):3-18 - PubMed
  51. Psychopharmacology (Berl). 2013 Feb;225(4):781-90 - PubMed
  52. Science. 2003 Jun 6;300(5625):1578-81 - PubMed
  53. Addiction. 2011 Mar;106(3):564-73 - PubMed
  54. Psychopharmacology (Berl). 2004 Nov;176(3-4):239-47 - PubMed
  55. Biol Psychiatry. 2016 Apr 1;79(7):578-85 - PubMed
  56. Am J Addict. 2005 Jan-Feb;14(1):64-72 - PubMed
  57. Curr Pharm Des. 2014;20(13):2114-25 - PubMed
  58. Dev Psychopathol. 2017 Oct;29(4):1253-1266 - PubMed
  59. Subst Abuse Rehabil. 2013 Jan 23;4:11-27 - PubMed
  60. Arch Gen Psychiatry. 2008 Jun;65(6):694-701 - PubMed
  61. Transl Psychiatry. 2016 Jan 12;6:e710 - PubMed
  62. Curr Opin Neurobiol. 2013 Apr;23(2):255-60 - PubMed
  63. Brain Res. 1987 Dec 8;436(1):193-8 - PubMed
  64. Addiction. 2000 Nov;95(11):1621-30 - PubMed
  65. Ann N Y Acad Sci. 2007 Feb;1097:1-11 - PubMed
  66. Brain. 2012 Jul;135(Pt 7):2245-55 - PubMed
  67. Neuropsychol Rev. 2013 Jun;23(2):117-37 - PubMed
  68. Addiction. 2018 Feb;113(2):257-265 - PubMed
  69. J Neurosci. 2014 Apr 16;34(16):5529-38 - PubMed
  70. Addict Biol. 2014 Mar;19(2):282-93 - PubMed
  71. Neurology. 2002 Nov 12;59(9):1337-43 - PubMed
  72. J Psychoactive Drugs. 2010 Sep;42(3):401-12 - PubMed
  73. Arch Gen Psychiatry. 2001 Oct;58(10):909-15 - PubMed
  74. Curr Drug Abuse Rev. 2008 Jun;1(2):114-23 - PubMed
  75. Drug Alcohol Depend. 2010 Aug 1;110(3):247-53 - PubMed
  76. J Child Psychol Psychiatry. 2007 Jun;48(6):592-600 - PubMed
  77. J Addict. 2013;2013:461029 - PubMed
  78. Biol Psychiatry. 2016 Apr 1;79(7):e17-31 - PubMed
  79. Hum Brain Mapp. 2014 May;35(5):2470-82 - PubMed
  80. J Psychiatr Res. 2011 Aug;45(8):1055-66 - PubMed
  81. Psychopharmacology (Berl). 2010 May;209(4):319-30 - PubMed
  82. Nature. 2015 Jun 18;522(7556):309-14 - PubMed
  83. J Psychopharmacol. 2011 Dec;25(12):1676-90 - PubMed
  84. Lancet Psychiatry. 2016 Oct;3(10):947-953 - PubMed
  85. Drug Alcohol Depend. 2015 Oct 1;155:275-83 - PubMed
  86. Biol Psychiatry. 1980 Oct;15(5):657-90 - PubMed
  87. Trends Cogn Sci. 2005 Sep;9(9):445-53 - PubMed
  88. Neurosci Biobehav Rev. 2020 Jan;108:358-369 - PubMed
  89. Drug Alcohol Depend. 2016 Dec 01;169:134-140 - PubMed
  90. MMWR Suppl. 2014 Jun 13;63(4):1-168 - PubMed
  91. Neuron. 2013 Apr 24;78(2):364-75 - PubMed
  92. J Psychopharmacol. 2006 Jan;20(1):14-23 - PubMed
  93. Neuropsychopharmacology. 2010 Feb;35(3):764-74 - PubMed
  94. Neuropsychologia. 2004;42(1):2-13 - PubMed
  95. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64 - PubMed
  96. Brain Res. 2010 Mar 4;1317:297-304 - PubMed
  97. Psychol Med. 2010 Mar;40(3):383-98 - PubMed
  98. JAMA. 2002 Mar 6;287(9):1123-31 - PubMed
  99. Behav Pharmacol. 2005 Sep;16(5-6):447-54 - PubMed
  100. Curr Drug Abuse Rev. 2008 Jan;1(1):99-111 - PubMed
  101. PLoS One. 2012;7(2):e31731 - PubMed
  102. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):148-54 - PubMed
  103. Neuroimage. 2018 Apr 1;169:496-509 - PubMed
  104. Neuropsychology. 2016 May;30(4):405-15 - PubMed
  105. J Neurosci. 2015 Jan 28;35(4):1505-12 - PubMed
  106. Neuropsychopharmacology. 2017 Apr;42(5):989-1000 - PubMed
  107. JAMA. 2000 Apr 19;283(15):2008-12 - PubMed
  108. J Psychiatry Neurosci. 2017 Mar;42(2):131-138 - PubMed
  109. Neurosci Biobehav Rev. 2019 Jan;96:45-55 - PubMed
  110. Neuroimage Clin. 2016 Jun 08;12:47-56 - PubMed
  111. Addict Behav. 2010 Nov;35(11):970-6 - PubMed
  112. Dev Cogn Neurosci. 2015 Dec;16:46-53 - PubMed
  113. Psychopharmacology (Berl). 2017 Jul;234(14):2149-2157 - PubMed
  114. Psychopharmacology (Berl). 1985;85(4):436-9 - PubMed
  115. J Clin Pharmacol. 2002 Nov;42(S1):41S-47S - PubMed
  116. Addiction. 2019 Oct 12;: - PubMed
  117. PLoS One. 2013;8(2):e55821 - PubMed
  118. Brain. 2003 Jun;126(Pt 6):1252-70 - PubMed
  119. Neuroimage. 2012 Feb 15;59(4):3845-51 - PubMed
  120. J Psychopharmacol. 2018 Mar;32(3):283-295 - PubMed
  121. Mol Psychiatry. 2015 Jun;20(6):772-7 - PubMed
  122. Addiction. 2011 Dec;106(12):2195-203 - PubMed
  123. Brain Res. 2000 Sep 22;877(2):407-10 - PubMed
  124. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):176-183 - PubMed
  125. PLoS Comput Biol. 2008 May 16;4(5):e1000073 - PubMed
  126. Br J Psychiatry. 2015 Jan;206(1):77-8 - PubMed
  127. Psychol Addict Behav. 2012 Sep;26(3):496-506 - PubMed
  128. NIDA Res Monogr. 1991;112:129-45 - PubMed
  129. Environ Health Perspect. 2000 Jun;108 Suppl 3:511-33 - PubMed
  130. Neuropsychopharmacology. 2003 Oct;28(10):1760-9 - PubMed
  131. Neuron. 1998 Mar;20(3):445-68 - PubMed
  132. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16913-8 - PubMed
  133. J Int Neuropsychol Soc. 2007 Sep;13(5):807-20 - PubMed
  134. Psychopharmacology (Berl). 2015 Aug;232(16):2939-50 - PubMed
  135. Handb Exp Pharmacol. 2015;228:215-36 - PubMed
  136. Eur Neuropsychopharmacol. 2007 Mar;17(4):289-97 - PubMed
  137. Psychiatry Clin Neurosci. 2013 Nov;67(7):483-92 - PubMed
  138. Drug Alcohol Depend. 2003 Apr 1;69(3):303-10 - PubMed
  139. J Addict Med. 2011 Mar;5(1):1-8 - PubMed
  140. Science. 1976 Jun 18;192(4245):1249-51 - PubMed
  141. Mol Pharmacol. 1988 Mar;33(3):297-302 - PubMed
  142. Drug Alcohol Rev. 2007 May;26(3):309-19 - PubMed
  143. Int Rev Neurobiol. 2016;129:33-65 - PubMed
  144. Eur Neuropsychopharmacol. 2019 Dec;29(2):257-265 - PubMed
  145. Pharmacol Biochem Behav. 2002 May;72(1-2):237-50 - PubMed
  146. Psychol Med. 2016 Jan;46(1):177-88 - PubMed
  147. J Psychopharmacol. 2017 Aug;31(8):1027-1034 - PubMed
  148. Drug Alcohol Depend. 2015 Oct 1;155:175-82 - PubMed
  149. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):60-67 - PubMed
  150. Brain Res. 1988 Mar 8;443(1-2):47-62 - PubMed
  151. Curr Pharm Des. 2016;22(42):6366-6379 - PubMed
  152. Psychiatry Res. 2018 Apr;262:46-54 - PubMed
  153. Arch Gen Psychiatry. 2009 Apr;66(4):442-51 - PubMed
  154. Pharmacol Biochem Behav. 2006 Mar;83(3):448-55 - PubMed

Publication Types

Grant support